Literature DB >> 12566825

In vivo tolerance assessment of skin after insertion of subcutaneous and cutaneous microdialysis probes in the rat.

F-X Mathy1, A-R Denet, B Vroman, P Clarys, A Barel, R K Verbeeck, V Préat.   

Abstract

The purpose of the study was to evaluate the trauma induced by insertion of the linear microdialysis probe in the subcutaneous and dermal tissue in the rat and to check if the microdialysis probe insertion affects transdermal drug delivery. Non-invasive bioengineering methods (TEWL, Laser Doppler Velocimeter, Chromameter) as well as histology were combined to characterize these effects. The results showed that the dermal and subcutaneous insertion of microdialysis probes did not change skin permeability, blood flow and color, confirming the safety of this technique. The probe depth did not influence the trauma. No significant physical damage after probe insertion was noticed. Thus, the present work validates the use of microdialysis in dermatopharmacokinetics studies after topical or systemic drug delivery. Copyright 2003 S. Karger AG, Basel

Entities:  

Mesh:

Year:  2003        PMID: 12566825     DOI: 10.1159/000068290

Source DB:  PubMed          Journal:  Skin Pharmacol Appl Skin Physiol        ISSN: 1422-2868


  4 in total

1.  Dermal microdialysis technique to evaluate the trafficking of surface-modified lipid nanoparticles upon topical application.

Authors:  Pinaki R Desai; Punit P Shah; Ram R Patlolla; Mandip Singh
Journal:  Pharm Res       Date:  2012-05-30       Impact factor: 4.200

Review 2.  In vivo methods for the assessment of topical drug bioavailability.

Authors:  Christophe Herkenne; Ingo Alberti; Aarti Naik; Yogeshvar N Kalia; François-Xavier Mathy; Véronique Préat; Richard H Guy
Journal:  Pharm Res       Date:  2007-11-06       Impact factor: 4.200

3.  Long-term calibration considerations during subcutaneous microdialysis sampling in mobile rats.

Authors:  Xiaodun Mou; Michelle R Lennartz; Daniel J Loegering; Julie A Stenken
Journal:  Biomaterials       Date:  2010-03-11       Impact factor: 12.479

4.  Dermal, subdermal, and systemic concentrations of granisetron by iontophoretic delivery.

Authors:  Ayyappa Chaturvedula; Dipty P Joshi; Carter Anderson; Russ Morris; Walter L Sembrowich; Ajay K Banga
Journal:  Pharm Res       Date:  2005-08-03       Impact factor: 4.200

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.